Monitor treatment efficacy, evaluate prognosis, and identify abnormalities across cardiovascular and cerebrovascular systems — all from a single 15-minute in-office assessment.

ANS testing reveals autonomic imbalances driving hypertension, enabling earlier intervention before clinical thresholds are crossed.
CAN and DAN are common in diabetic patients. ANS testing detects them early, when intervention can alter disease trajectory.
Pulse Wave Velocity and vascular studies identify arterial stiffness and endothelial dysfunction across your patient panel.
Serial ANS testing provides objective data to monitor whether medications and lifestyle interventions are working.
US MedResources equips internal medicine practices nationwide with FDA-cleared autonomic and vascular diagnostic technology. From New York to Los Angeles, Chicago to Miami, practices rely on VitalScan ANS+ for early detection of internal medicine conditions — with CPT-billable testing that fits into a single patient visit.
Request an ROI & Quote95921–95924Autonomic nervous system function testing93922–93971Vascular studies including arterial Doppler and PWVEstimated monthly revenue
3 tests/day × ~$190 avg = $11,400/month
Based on 3 tests per day, 20 working days per month. Actual reimbursement varies by payer and region.
Get a personalized growth plan with clinical workflow, CPT billing guidance, and financing options — including Section 179 and grant pathways.